Cytokinetics, Inc. (CYTK)
65.60
-0.02
(-0.03%)
USD |
NASDAQ |
Oct 02, 16:00
65.59
-0.01
(-0.02%)
After-Hours: 20:00
Cytokinetics Max Drawdown (5Y) : 72.39% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 72.39% |
| August 31, 2026 | 72.39% |
| July 31, 2026 | 72.39% |
| June 30, 2026 | 72.39% |
| May 31, 2026 | 72.39% |
| April 30, 2026 | 72.39% |
| March 31, 2026 | 72.39% |
| February 28, 2026 | 72.39% |
| January 31, 2026 | 72.39% |
| December 31, 2025 | 72.39% |
| November 30, 2025 | 72.39% |
| October 31, 2025 | 72.39% |
| September 30, 2025 | 72.39% |
| August 31, 2025 | 72.39% |
| July 31, 2025 | 72.39% |
| June 30, 2025 | 72.39% |
| May 31, 2025 | 72.39% |
| April 30, 2025 | 68.01% |
| March 31, 2025 | 62.81% |
| February 28, 2025 | 61.54% |
| January 31, 2025 | 58.14% |
| December 31, 2024 | 57.10% |
| November 30, 2024 | 55.89% |
| October 31, 2024 | 55.71% |
| September 30, 2024 | 55.71% |
| Date | Value |
|---|---|
| August 31, 2024 | 55.71% |
| July 31, 2024 | 55.71% |
| June 30, 2024 | 55.71% |
| May 31, 2024 | 55.71% |
| April 30, 2024 | 53.24% |
| March 31, 2024 | 53.24% |
| February 29, 2024 | 65.00% |
| January 31, 2024 | 65.00% |
| December 31, 2023 | 65.00% |
| November 30, 2023 | 65.24% |
| October 31, 2023 | 65.24% |
| September 30, 2023 | 65.24% |
| August 31, 2023 | 65.24% |
| July 31, 2023 | 65.24% |
| June 30, 2023 | 65.24% |
| May 31, 2023 | 65.24% |
| April 30, 2023 | 65.24% |
| March 31, 2023 | 65.24% |
| February 28, 2023 | 65.24% |
| January 31, 2023 | 65.24% |
| December 31, 2022 | 65.24% |
| November 30, 2022 | 65.24% |
| October 31, 2022 | 65.24% |
| September 30, 2022 | 65.24% |
| August 31, 2022 | 65.24% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Bristol Myers Squibb Co. | 47.67% |
| Ionis Pharmaceuticals, Inc. | 70.27% |
| Vertex Pharmaceuticals, Inc. | 41.60% |
| Krystal Biotech, Inc. | 53.42% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 5.168 |
| Beta (5Y) | 0.4065 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.23% |
| Historical Sharpe Ratio (5Y) | 0.1181 |
| Historical Sortino (5Y) | 0.4044 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 17.46% |